Kristopher Clark is a Respiratory physician. OpenAlex indexes 63 publications with 4,022 citations (h-index 25); ClinicalTrials.gov lists 1 registered study matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
1020 Youngs Rd Ste 100
Williamsville, NY 142212698
Telephone
716-961-9900Provider last certified this registry record 6 Nov 2023.
Clinical trials
- Titrated Ambulatory Oxygen in Fibrotic ILD and COPD With Isolated Exertional Hypoxemia
Sponsor: State University of New York at Buffalo
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
3 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Astellas Pharma US IncProgram year20252 payments
- United Therapeutics CorporationProgram year20251 payment
- Boehringer Ingelheim Pharmaceuticals, Inc.Program year20241 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Respiratory
66.3%beta2-Adrenergic Agonist33.3%Albuterol Sulfate Hfa100%Part D≥35 patientsCorticosteroid33%Breztri Aerosphere56%Symbicort26%Trelegy Ellipta18%Part D<11 patientsMetabolism & gastrointestinal
33.7%Corticosteroid22.5%Prednisone100%Part D≥22 patientsProton pump inhibitor6.7%Omeprazole100%Part D<11 patients+ 1 more class in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Amyloid pathology reduces dynamic range and disrupts neural coding in a mouse model of Alzheimer’s Disease
bioRxiv (Cold Spring Harbor Laboratory)
2025 - A Ramped Treadmill Protocol Exercise Test Identifies Higher Ambulatory Oxygen Needs in Idiopathic Pulmonary Fibrosis and Chronic Obstructive Pulmonary Disease
Annals of the American Thoracic Society
2024 - Supplemental Oxygen Therapy in Interstitial Lung Disease: A Narrative Review
Annals of the American Thoracic Society
2023 - Salt-inducible kinase 2 regulates fibrosis during bleomycin-induced lung injury
Journal of Biological Chemistry
2022
Similar KOLs
Other experts from the same institution or the same specialty.
Tim Driscoll
The University of Sydney
Francesco Saverio Violante
IRCCS Azienda Ospedliero-Universitaria di Bologna Policlinico di Sant'Orsola
Mark A. Rubin
University of Bern
Marc Humbert
Inserm
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”